MA35742B1 - Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques - Google Patents

Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Info

Publication number
MA35742B1
MA35742B1 MA37145A MA37145A MA35742B1 MA 35742 B1 MA35742 B1 MA 35742B1 MA 37145 A MA37145 A MA 37145A MA 37145 A MA37145 A MA 37145A MA 35742 B1 MA35742 B1 MA 35742B1
Authority
MA
Morocco
Prior art keywords
antihelminthics
quinolinylmethyl
sulfonamide
derivatives
compounds
Prior art date
Application number
MA37145A
Other languages
English (en)
Inventor
George Philip Lahm
Moumita Kar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of MA35742B1 publication Critical patent/MA35742B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule 1, leurs
MA37145A 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques MA35742B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161563926P 2011-11-28 2011-11-28
PCT/US2012/063802 WO2013081783A1 (fr) 2011-11-28 2012-11-07 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Publications (1)

Publication Number Publication Date
MA35742B1 true MA35742B1 (fr) 2014-12-01

Family

ID=47179004

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37145A MA35742B1 (fr) 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Country Status (20)

Country Link
US (1) US20140315857A1 (fr)
EP (1) EP2785694A1 (fr)
JP (1) JP2015502936A (fr)
KR (1) KR20140094026A (fr)
CN (1) CN103958476A (fr)
AR (1) AR089014A1 (fr)
AU (1) AU2012346433A1 (fr)
BR (1) BR112014012759A8 (fr)
CA (1) CA2855001A1 (fr)
CL (1) CL2014001377A1 (fr)
CO (1) CO6980661A2 (fr)
IL (1) IL232404A0 (fr)
MA (1) MA35742B1 (fr)
MX (1) MX2014006317A (fr)
PH (1) PH12014501181A1 (fr)
RU (1) RU2014126367A (fr)
SG (1) SG11201402664VA (fr)
TN (1) TN2014000166A1 (fr)
TW (1) TW201326128A (fr)
WO (1) WO2013081783A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014065411A1 (fr) * 2012-10-26 2014-05-01 株式会社エス・ディー・エス バイオテック Dérivé de sulfonamide utilisé comme agent de lutte contre les organismes nuisibles dans le domaine agricole/horticole
WO2014099837A1 (fr) * 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anti-helminthique
MY196327A (en) * 2016-11-11 2023-03-24 Bayer Animal Health Gmbh New Anthelmintic Quinoline-3-Carboxamide Derivative
JP7210483B2 (ja) * 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
EP4291555A1 (fr) * 2021-02-09 2023-12-20 Celgene Corporation Sulfamides et leur utilisation pour le traitement d'infections et de maladies helminthiques
US11905306B2 (en) 2021-12-21 2024-02-20 Southern Research Institute Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815604A (en) 1922-10-31 1931-07-21 Winthrop Chem Co Organic mercury compound
US1679404A (en) 1926-02-04 1928-08-07 Rockwood Sprinkler Co Massachusetts Constant-alarm device for alarm valves
US1959705A (en) 1931-08-12 1934-05-22 Standard Steel Car Corp Car door
US5299582A (en) 1991-09-16 1994-04-05 Little Rapids Corporation Surgical isolation apparatus
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
CN1082814C (zh) 1995-03-20 2002-04-17 麦克公司 球孢子酸衍生物
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての8a−アザライド
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6239112B1 (en) 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
CA2292359C (fr) 1999-01-28 2004-09-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
ATE243703T1 (de) 2000-01-27 2003-07-15 Pfizer Prod Inc Antibiotische azalid-zusammensetzungen
US6399796B2 (en) 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
AU2003249503A1 (en) 2002-03-08 2003-09-29 Schering-Plough, Ltd. Novel florfenicol-type antibiotics
AU2004278095B2 (en) * 2003-09-18 2010-06-24 Basf Se 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
EP1696934B1 (fr) 2003-12-23 2013-05-29 Schering-Plough Ltd. Promedicament de florfenicol dote d'une meilleure hydrosolubilite
WO2005066119A2 (fr) 2003-12-31 2005-07-21 Schering-Plough Ltd. 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols antibacteriens et procede de preparation de ces derniers
CA2551867C (fr) 2003-12-31 2010-08-17 Schering-Plough Ltd. Lutte contre les parasites chez des animaux, a l'aide de derives d'imidazo[1,2-b]pyridazine
EP1571150A1 (fr) 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Procédé pour la prparation des inhibiteurs de tryptase
DE602005009381D1 (de) 2004-09-23 2008-10-09 Schering Plough Ltd Bekämpfung von parasiten in tieren durch verwendung neuer trifluormethansulfonanilidoximetherderivate
US7642391B1 (en) 2005-03-04 2010-01-05 Iowa State University Research Foundation, Inc. Palladium-catalyzed coupling of aryl halides with alkynes
KR20070112853A (ko) 2005-03-16 2007-11-27 바스프 악티엔게젤샤프트 절지류 해충 방제를 위한 n-(4-피리딜)메틸설폰아미드의용도
EP1890547A2 (fr) 2005-06-09 2008-02-27 Schering-Plough Ltd. Controle de parasites chez des animaux a l'aide de derives de n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide et de n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide
US20070285554A1 (en) 2005-10-31 2007-12-13 Dor Givon Apparatus method and system for imaging
WO2007093599A1 (fr) * 2006-02-14 2007-08-23 Basf Se Composes pyridin-4-ylmethylamide destines a lutter contre les organismes nuisibles
MX2008011531A (es) * 2006-03-15 2008-09-18 Basf Se Derivados de quinolina y su uso como pesticidas.
WO2007147762A1 (fr) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Dérivés d'arylsulfonamidyl tétraline et leurs utilisations
CA2656875C (fr) 2006-07-11 2011-09-06 Pfizer Inc. Composes de carboxyamide bicycliques a n-bicycloalkyle substitue
CA2662021A1 (fr) * 2006-09-12 2008-03-20 Basf Se Composes de quinolinylmethyle
MX2009006543A (es) 2006-12-20 2009-06-26 Amgen Inc Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer.
WO2008090434A1 (fr) 2007-01-25 2008-07-31 Pfizer Japan Inc. Composés n-bicyclicalkyle bicyclique carboxyamide substitués
TWI482771B (zh) * 2009-05-04 2015-05-01 Du Pont 磺醯胺殺線蟲劑
US20140113934A1 (en) * 2011-06-20 2014-04-24 E I Du Pont De Nemours And Company Heterocyclic compounds for treating helminth infections

Also Published As

Publication number Publication date
SG11201402664VA (en) 2014-06-27
IL232404A0 (en) 2014-06-30
US20140315857A1 (en) 2014-10-23
PH12014501181A1 (en) 2014-09-08
CO6980661A2 (es) 2014-06-27
BR112014012759A2 (pt) 2017-06-13
CN103958476A (zh) 2014-07-30
EP2785694A1 (fr) 2014-10-08
AU2012346433A1 (en) 2014-05-08
TN2014000166A1 (en) 2015-09-30
CA2855001A1 (fr) 2013-06-06
WO2013081783A1 (fr) 2013-06-06
MX2014006317A (es) 2014-06-23
RU2014126367A (ru) 2016-01-27
TW201326128A (zh) 2013-07-01
BR112014012759A8 (pt) 2017-06-20
AR089014A1 (es) 2014-07-23
KR20140094026A (ko) 2014-07-29
CL2014001377A1 (es) 2014-10-17
JP2015502936A (ja) 2015-01-29

Similar Documents

Publication Publication Date Title
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
MA35926B1 (fr) Pyrrolidine-2-carboxamides substitués
MA37519B1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
EA201590999A1 (ru) Пирролобензодиазепины и их конъюгаты
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
MA35086B1 (fr) Compose de triazolopyridine
MA38645B1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA35905B1 (fr) Composés de bêta-lactame à substitution amidine, leur préparation et leur utilisation en tant qu'agents antibactériens
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
MA35357B1 (fr) Composes de type anilines
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
MA35819B1 (fr) Composés hétéroaryl pyridones et aza-pyridones en tant qu'inhibiteurs de l'activité btk
MA34963B1 (fr) Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
CR20130045A (es) Compuestos terapéuticos
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201590854A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
UA107455C2 (uk) Похідні індолу як протиракові агенти
EA201791321A1 (ru) Составы ингибитора lfa-1
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
TR201902057T4 (tr) Tetrasiklin bileşikleri.
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k